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Knowledge on pancreaticobiliary reﬂux in normal pancreaticobiliary junction and their pathologic
implications has experienced tremendous progress during the last few years. This article reviews the
current knowledge on this condition and its pathological implications on gallbladder diseases. Many
publications with different levels of evidence were found supporting biliary carcinogenesis associated
with pancreaticobiliary reﬂux in normal and abnormal pancreaticobiliary junction. Also, there are many
publications supporting the common occurrence of pancreaticobiliary reﬂux in normal pan-
creaticobiliary junction, and sphincter of Oddi dysfunction as the most plausible cause of this condition.
Although an important body of research has been published regarding pancreaticobiliary reﬂux in
normal pancreaticobiliary junction and their clinical signiﬁcance, the current evidence does not fully
support what has been suggested. The reﬂux of pancreatic enzymes into the bile tract and gallbladder is
a fascinating subject of study which is open to active research. The ﬁnal demonstration of the patho-
physiology and consequences of PBR in NPBL and support by evidence level type I would constitute
a major breakthrough in the understanding and eventually in the treatment of gallbladder diseases.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Pancreaticobiliary reﬂux (PBR) has been associated to prolifer-
ative changes of the biliary epithelium, hyperplasia and
carcinoma.1e3 This sequence of events caused by PBR has been
studied in patients with biliary tract anomalies.4e19 Recently, it has
been recognized that PBR is a phenomenon occurring in patients
with a normal pancreaticobiliary junction (NPBJ)20e29; has been
associated to gallbladder carcinoma30e38; and has been suggested
that could play a role in gallstone formation through inﬂammatory
changes of the gallbladder mucosa.20,29,36,39 The pathophysiology
and clinical importance of this phenomenon has begun to be
elucidated attributing the occurrence of PBR to biliary tree motility
disorders involving the sphincter of Oddi (SO).27,29,36,39 Herein, the
current knowledge on PBR in NPBJ and its pathologic implications
is discussed.P.O. Box 912, La Serena, IV
82.
ciates Ltd. Published by Elsevier Lt2. Carcinogenesis associated to pancreaticobiliary reﬂux
Most of the knowledge on gallbladder carcinogenesis associated
with PBR comes from studies on patients with anomalous pan-
creaticobiliary junction. Formore than60yearshasbeenknown that
the reﬂux of pancreatic juice plays an important role in gallbladder
carcinogenesis.2,9 Gallbladder carcinoma associated with PBR was
ﬁrst described in patients with choledochal cysts.2,4,40 The presence
of an anomalous pancreaticobiliary junction in 96% of these
patients,41e45 causes reﬂuxof pancreatic juice into the common bile
duct and into the gallbladder, where active pancreatic enzymes
concentrate leading to chronic inﬂammation with associated
mucosal malignant changes: hyperplasia, metaplasia, dysplasia,
carcinoma in-situ and invasive carcinoma.6,9,12,16e19,40,43e47 In
patients with gallbladder cancer, an incidence of 8.7%e16.7% of
anomalous pancreaticobiliary maljunction has been found17,45; on
the other hand, gallbladder carcinoma has an incidence as high as
24.6% in patients with anomalous pancreaticobiliary junction.14,17
The mixture of bile acids and pancreatic activated enzymes
present in PBR causes injury to DNA which shows aneuploid or
polyploid patterns, accelerating the cell cycle of the biliary epithe-
lium of patients with PBR.9,14,17e19 A high prevalence of K-ras
mutations are found in gallbladder carcinoma in patients withd. All rights reserved.
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present in malignant, precancerous dysplastic and chronically
inﬂamed bile ducts in patientswith choledochal cysts and abnormal
pancreaticobiliary junction, suggesting that the reﬂux of active
pancreatic enzymes causes these cellular andmolecular alterations,
and that the biliary epithelium of patients with PBR should be
considered as an epithelium with high carcinogenic poten-
tial.7,9,15,16,44 Mutations in tumor suppressor genes, microsatellite
instability, and mRNA indexes signiﬁcantly increased have been
found in gallbladder cancer in PBR, and also in PBR without gall-
bladder cancer.9,18 Bile acid fractions, amino acids acting as muta-
genic substances, and active pancreatic enzymes in bile such as
amylase, lipase, and others promote carcinoma under conditions of
infection, inﬂammation, and bile stasis.6,7,9,17,19 Moreover, phos-
pholipase A2 hydrolyzes lecithin into lysolecithin which is harmful
for the mucosal barrier injuring the cell membrane.6,7,9,17,47
The levels of pancreatic enzymes, mainly amylase, have been
reported to be extremely high in patients with gallbladder cancer
and PBR in NPBJ, compared to patients with benign gallbladder
diseases within the same study.22,26,31,34,36 Although there has not
been any explanation on why amylase levels are so highly elevated
in those cases, a strong correlation has been found between gall-
bladder cancer and higher levels of amylase in gallbladder bile of
patients with PBR and NPBJ.26,30,33,36 In patients with higher
amylase levels thickening of the gallbladder mucosa was a signiﬁ-
cant manifestation, and histological examination showed a high
incidence of metaplastic changes compared to patients with lower
levels of amylase.26,36,37 Markers of increased cellular kinetics, such
as Ki-67LI, were highly elevated in patients with higher amylase
levels compared to patients with lower amylase levels in patients
with gallbladder cancer.26,36 Moreover, studies on non-cancerous
epithelium of patients with PBR and NPBJ, have found an
increased Ki-67LI, COX-2 expression and overexpression, and
mutations of K-ras gene in patients with higher amylase levels31,32;
and increased Ki-67LI in patients with hyperplastic or dysplastic
gallbladder epithelium without gallbladder cancer with a higher
mean Ki-67LI in dysplastic epithelium compared to metaplastic
epithelium.31 Dysplasia, hyperplasia and intestinal metaplasia are
frequently found in patients with PBR and NPBJ.31,34,37 These ﬁnd-
ings suggest that higher levels of pancreatic enzymes in bile
constitute a risk factor for gallbladder cancer, and that the sequence
of hyperplasiaemetaplasia-dysplasiaecarcinoma seen in patients
with abnormal pancreaticobiliary junction might be similar for
patients with NPBJ and PBR.30e34,36 It has been assumed that the
pathophysiological changes leading to gallbladder carcinoma in
patients with NPBJ and PBR parallel the pathophysiology described
in studies on patients with anomalous pancreaticobiliary junction
and gallbladder carcinoma.22,31,33,34,36 Gallbladder carcinogenesis
in patients with PBR is a multifactorial and multistage dynamic
process involving multiple genetic changes and proliferative
inductions of the gallbladdermucosa induced by the reﬂuxof active
pancreatic enzymes into the biliary tree and pooling in the gall-
bladder lumen. Gallbladder cancer in anomalous pancreaticobiliary
junction is associated to a non-dilated common bile tract, in which
stasis of the reﬂuxed pancreatic juice occurs in the gallbladder and
causes the variety of changes previously reviewed, leading to
gallbladder cancer. The pathophysiology of gallbladder cancer in
NPBJ probably resembles this well-known condition.
3. Pancreaticobiliary reﬂux in normal pancreaticobiliary
junction
Normal pancreaticobiliary junction was deﬁned as the union of
the common bile duct and the main pancreatic duct inside the
duodenal wall where the SO surrounds them with muscularfascicles which regulate the ﬂow of bile and pancreatic juice.48e50
According to this deﬁnition, reﬂux of pancreatic juice into the
biliary tract in patients with a NPBJ could be explained only by an
improper functioning sphincter.29,34,36,39,48
A variety of methods have been employed to demonstrate PBR.
Some investigators have used radioimmunoassay of biliary trypsin
on bile samples taken directly from a T tube inserted directly into
the common bile duct after surgery.20,51 A widely used method has
been the bile sample taken directly from the gallbladder at the time
of cholecystectomy and pancreatic amylase and lipase determina-
tion by the colorimetric or enzymaticmethods.20,23,24,29,36,52 Others
have measured pancreatic enzymes in bile using samples taken
directly from the bile duct in patients undergoing endoscopic
retrograde cholangiopancreatography (ERCP) and analyzing the
samples with enzymatic methods or Western-blotting
tests.24e28,30e34,36,53 Others have employed magnetic resonance
cholangiopancreatography (MRCP) with secretin injection to
stimulate the SO to indirectly show reﬂux of pancreatic juice into
the biliary tract.21,22,24,25,27 I believe that a most accurate method to
measure PBR is directly sampling the bile from the gallbladder
during cholecystectomy, before any manipulation in the triangle of
Calot area or over the common bile duct has been performed.29,36,39
No one has determined and validated normal values or levels of
pancreatic enzymes in bile.1,27,29,36,39 However, most researchers
use as a reference the normal values of pancreatic enzymes in
plasma to deﬁne patients with PBR.22e24,27,29,36,39,51,52 The argu-
ment favoring this assumption is that any patient with bile levels of
pancreatic enzymeswithin the normal plasma values does not have
PBR. In a recent investigation we determined that patients without
gallstones have minimal or do not have any levels of pancreatic
enzymes in their gallbladders.29,36 Consequently, the “normal”
values of pancreatic enzymes in bile should be close to zero.
Anderson et al. determined the concentration of pancreatic
enzymes, amylase and lipase, in bile obtained from the gallbladder
in 70 patients and found the levels of amylase highly elevated in
87% cases and lipase in 66%, they concluded that the reﬂux of
pancreatic enzymes may initiate chronic inﬂammatory changes in
the gallbladder and could play a role in gallstone formation and in
the pathogenesis of some cases of acute cholecystitis.20 This
premise, was also followed by Josef Vracko who investigated the
role of PBR in acute cholecystitis.23,51 Vracko et al. postulate that
endoscopic sphincterotomy releasing the common channel outlet
obstruction could initially improve the course of acute cholecystitis
in elderly patients, reducing the risk of biliary sepsis, and delaying
surgery until their conditions are improved in order to undergo
elective surgery at a later time and avoid emergency surgery.23,51
Pancreatic enzymes were found to be extremely elevated in
patients with initial edematous acute cholecystitis compared with
patients with late gangrenous cholecystitis and patients with
chronic symptomatic cholelithiasis; suggesting that in some
patients, acute cholecystitis could be initiated by the reﬂux of
pancreatic enzymes into the gallbladder due to SO dysfunction or
an obstructing gallstone in the papilla of Vater or both.23 Conse-
quently, although not conclusively proven, the role of PBR in
patients with acute cholecystitis might be related to a sudden
functional or mechanical obstruction of the SO leading to an
excessive reﬂux of active injurious pancreatic enzymes into the
common bile duct and gallbladder, initiating a cascade of events
ultimately leading to acute cholecystitis. This theory ﬁnds its clin-
ical application in the proposal of endoscopic sphincterotomy in the
early course of acute cholecystitis within the ﬁrst 72 h after the
onset of symptoms, as an alternative to more invasive surgery in
elderly frail patients.23,51
Continuous PBR causes chronic inﬂammation and injury of the
biliary tract mucosa and particularly of the gallbladder mucosa
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high levels.22,24,25,29,31,36 High levels of pancreatic enzymes have
been found within the whole spectrum of gallbladder diseases,
benign and malignant, including acute and chronic cholecystitis,
common bile duct stones, gallbladder polyps, and gallbladder
cancer.20,22,24,26,29,36 This suggests that PBR has a role in the whole
spectrum of gallbladder diseases.20,24,27,29,36,39 Initial and chronic
inﬂammatory changes of the gallbladder mucosa induced by active
pancreatic enzymes could play a role in gallstone forma-
tion.20,27,29,36,39 The reﬂux on pancreatic enzymes causes chronic
inﬂammation of the gallbladdermucosa,20e29,36,51,52 whichmodiﬁes
the hepatic bile in ways other than the reabsorption of ﬂuids and
electrolytes with the addition of total proteins such as mucin
and albumin, which increase the nucleation time leading to
formation of biliary sludge, microlithiasis and ultimately gall-
stones.20,27,29,36,39,53,54 Motility disorders of the gallbladder and
biliary tree; including spastic episodes of the SO that could be
inﬂuenced by gender, hormones and genetic predisposition,
and associated with PBR leading to bile tract and gallbladder
mucosa chronic injury; could play a role in the etiology of gallstones,
chronic gallbladder disease and ultimately gallbladder cancer,
constituting only different continuous stages of a common patho-
logic entity.29,36,39
4. The role of the sphincter of oddi in pancreaticobiliary
reﬂux
Pancreaticobiliary maljunction has been deﬁned as a union of
the pancreatic and biliary ducts that is located outside the duodenal
wall forming amarkedly long common channel.54e56 Consequently,
NPBJ must be located inside the duodenal wall where the sphinc-
teric mechanism provided by the muscular fascicles of the SO can
inﬂuence the normal antegrade ﬂow of bile and pancreatic juice.
The human bile duct lacks a contractile muscle layer.51 Therefore,
the ﬂow of bile and pancreatic juice toward the duodenum is
a consequence of gallbladder activity and intraductal bile and
pancreatic ducts pressures, which depend on the production of bile
and pancreatic juice respectively, and is regulated by the SO. The
normal sphincter activity direct the ﬂowof bile and pancreatic juice
toward the duodenum by antegrade phasic contractions,57 conse-
quently, in patients with PBR and NPBJ, the only plausible expla-
nation for reﬂux of pancreatic juice into the biliary tract is an
anomaly in the normal function of the SO causing a functional
obstruction to the normal ﬂow and retrograde contractions
favoring the reﬂux of pancreatic juice into the biliary tract, because
the intraluminal pressure of the pancreatic duct is higher than the
intraluminal pressure of the common bile
duct.23,27,29,34,36,50e53,58,59The SO is a smooth muscle structure
measuring approximately 1 cm in length that is situated at the
junction of the bile duct, pancreatic duct and duodenum.50,60 The
SO normally produces high-pressure phasic antegrade contractions
that are superimposed on a modest basal pressure, the phasic
contractions propel small volumes of either bile or pancreatic juice
into the duodenum.50,55,59e62 In man, most ﬂow occurs between
the phasic contractions.50,59e62 The SO function is inﬂuenced by
a number of neural stimuli, circulating hormones, and duodenal
activity secondary to ingestion of meals.50 During fasting, the SO
demonstrates regular phasic contractile activity which alternates
with the interdigestive motor activity of the duodenum.50,59,61,62
During duodenal phases I and II, the SO contracts at the rate of
2e4 contractions per minute without a quiescent phase;
approaching duodenum phase III, the SO also increases its
contractile activity concluding at the same time, this pattern
repeats over the same period as duodenal activity.50,59e62 The fact
that the SO continues to contract during the quiescence ofduodenal phase I supports the independent nature of SO motility.
This pattern of function demonstrated by the SO, supports the
theory regarding the cause of PBR in NPBJ, which states that spasms
of the SO not related to the migrating myoelectric complex is the
cause of this phenomenon.23,27,36,39,595. Conclusions
The reﬂux of pancreatic enzymes into the bile tract and gall-
bladder is a fascinating subject of study which is open to active
research. The ﬁnal demonstration of the pathophysiology and
consequences of PBR in NPBL and support by evidence level type I
would constitute a major breakthrough in the understanding and
eventually in the treatment of gallbladder diseases.
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